跳至主要内容
临床试验/CTRI/2024/06/069245
CTRI/2024/06/069245尚未招募2 期

Effectiveness of individualized homoeopathic treatment in primary tumours of the brain:an open label,prospective,clinical study - NI

ational Institute of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who are diagnosed cases of primary tumours of brain.
  • Patients of age 18 -65 years.
  • Patients of all genders and religions and all socio-economic status.
  • Patient who are willing to participate in the study and giving informed consent.

排除标准

  • Patients who are having secondary metastasis to brain.
  • Patients associated with serious systemic disorders or life-threatening infections.
  • Pregnant and lactating women.
  • Self-reported immune-compromised conditions.
  • Patients who are not willing to take part in the study.

研究者

发起方
ational Institute of Homoeopathy

相似试验